Published in Trends Parasitol on May 15, 2012
Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease. Annu Rev Immunol (2014) 1.38
CD4 T-cell subsets in malaria: TH1/TH2 revisited. Front Immunol (2015) 1.20
Exposure-dependent control of malaria-induced inflammation in children. PLoS Pathog (2014) 1.16
Young lives lost as B cells falter: what we are learning about antibody responses in malaria. J Immunol (2013) 1.02
RTS,S vaccination is associated with serologic evidence of decreased exposure to Plasmodium falciparum liver- and blood-stage parasites. Mol Cell Proteomics (2014) 0.99
HIV and co-infections. Immunol Rev (2013) 0.92
Malaria Vaccines: Moving Forward After Encouraging First Steps. Curr Trop Med Rep (2015) 0.82
Immunoregulation in human malaria: the challenge of understanding asymptomatic infection. Mem Inst Oswaldo Cruz (2015) 0.77
CD4+ T cell response correlates with naturally acquired antibodies against Plasmodium vivax tryptophan-rich antigens. Infect Immun (2015) 0.77
Characterization of Caveola-Vesicle Complexes (CVCs) Protein, PHIST/CVC-8195 in Plasmodium vivax. Korean J Parasitol (2016) 0.75
RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet (2009) 58.77
Genome sequence of the human malaria parasite Plasmodium falciparum. Nature (2002) 37.89
Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med (2009) 33.25
Pattern recognition receptors and inflammation. Cell (2010) 21.05
Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet (2012) 17.62
An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell (2005) 15.46
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science (2011) 15.45
Indicators of life-threatening malaria in African children. N Engl J Med (1995) 13.17
Gamma-globulin and acquired immunity to human malaria. Nature (1961) 13.07
Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature (2008) 10.80
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med (2011) 10.79
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature (2010) 10.37
Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol (2010) 8.87
Pyrethroid resistance in African anopheline mosquitoes: what are the implications for malaria control? Trends Parasitol (2010) 8.80
Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol (2007) 7.58
Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect Dis (2010) 7.42
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol (2008) 7.18
A genomic storm in critically injured humans. J Exp Med (2011) 6.67
Computational solutions to large-scale data management and analysis. Nat Rev Genet (2010) 6.58
Acquired immunity to malaria. Clin Microbiol Rev (2009) 6.24
Systems biology of vaccination for seasonal influenza in humans. Nat Immunol (2011) 6.09
A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity (2008) 5.89
Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity (2008) 5.82
Immunity to malaria: more questions than answers. Nat Immunol (2008) 5.71
Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis (2002) 5.43
Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat Immunol (2008) 5.10
Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med (2010) 4.98
Cell type-specific gene expression differences in complex tissues. Nat Methods (2010) 4.75
Cellular decision making and biological noise: from microbes to mammals. Cell (2011) 4.44
Direct RNA sequencing. Nature (2009) 4.37
Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med (2008) 4.21
Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat Med (1999) 4.18
Protection against a malaria challenge by sporozoite inoculation. N Engl J Med (2009) 4.03
Pattern recognition receptors and control of adaptive immunity. Immunol Rev (2009) 3.91
Malaria in pregnancy: pathogenesis and immunity. Lancet Infect Dis (2007) 3.88
Standardizing immunophenotyping for the Human Immunology Project. Nat Rev Immunol (2012) 3.81
Distinct physiological states of Plasmodium falciparum in malaria-infected patients. Nature (2007) 3.69
Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc Natl Acad Sci U S A (2005) 3.59
Immune effector mechanisms in malaria. Parasite Immunol (2006) 3.43
Key issues in conducting a meta-analysis of gene expression microarray datasets. PLoS Med (2008) 3.31
A field trial to assess a blood-stage malaria vaccine. N Engl J Med (2011) 3.20
A global network for investigating the genomic epidemiology of malaria. Nature (2008) 3.16
Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet (2011) 2.98
Deconvolution of blood microarray data identifies cellular activation patterns in systemic lupus erythematosus. PLoS One (2009) 2.98
A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci U S A (2010) 2.90
Illumina universal bead arrays. Methods Enzymol (2006) 2.88
The $1,000 genome, the $100,000 analysis? Genome Med (2010) 2.79
Highly multiparametric analysis by mass cytometry. J Immunol Methods (2010) 2.77
Sickle cell trait is associated with a delayed onset of malaria: implications for time-to-event analysis in clinical studies of malaria. J Infect Dis (2008) 2.77
The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis. PLoS Med (2010) 2.61
Experimental human challenge infections can accelerate clinical malaria vaccine development. Nat Rev Immunol (2011) 2.53
Applying mass spectrometry-based proteomics to genetics, genomics and network biology. Nat Rev Genet (2009) 2.44
Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics (2008) 2.43
Systems vaccinology. Immunity (2010) 2.36
A genomic approach to human autoimmune diseases. Annu Rev Immunol (2010) 2.10
Humanized mice with ectopic artificial liver tissues. Proc Natl Acad Sci U S A (2011) 2.03
The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections. PLoS Pathog (2010) 2.03
Advances and challenges in malaria vaccine development. J Clin Invest (2010) 2.03
Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar J (2008) 2.00
Characterization and improvement of RNA-Seq precision in quantitative transcript expression profiling. Bioinformatics (2011) 2.00
Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar J (2007) 1.97
Whole-transcriptome RNAseq analysis from minute amount of total RNA. Nucleic Acids Res (2011) 1.97
Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update. J Infect Dis (2007) 1.94
Retracted Branched tricarboxylic acid metabolism in Plasmodium falciparum. Nature (2010) 1.92
Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates. Infect Immun (2008) 1.87
Assessing the human immune system through blood transcriptomics. BMC Biol (2010) 1.86
A 2020 vision for vaccines against HIV, tuberculosis and malaria. Nature (2011) 1.80
Global metabolic responses of NMRI mice to an experimental Plasmodium berghei infection. J Proteome Res (2008) 1.78
Evaluation of the psoriasis transcriptome across different studies by gene set enrichment analysis (GSEA). PLoS One (2010) 1.75
Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis. PLoS One (2011) 1.74
Malaria primes the innate immune response due to interferon-gamma induced enhancement of toll-like receptor expression and function. Proc Natl Acad Sci U S A (2009) 1.70
Malaria in pregnancy: small babies, big problem. Trends Parasitol (2011) 1.70
Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans. J Infect Dis (2011) 1.67
Genomewide analysis of the host response to malaria in Kenyan children. J Infect Dis (2005) 1.66
Report of a consultation on the optimization of clinical challenge trials for evaluation of candidate blood stage malaria vaccines, 18-19 March 2009, Bethesda, MD, USA. Vaccine (2009) 1.41
Ex vivo perfusion of human spleens maintains clearing and processing functions. Blood (2005) 1.39
The RTS,S malaria vaccine. Vaccine (2010) 1.39
The multitasking organ: recent insights into skin immune function. Immunity (2011) 1.38
Common and divergent immune response signaling pathways discovered in peripheral blood mononuclear cell gene expression patterns in presymptomatic and clinically apparent malaria. Infect Immun (2006) 1.33
Biomarker discovery in heterogeneous tissue samples -taking the in-silico deconfounding approach. BMC Bioinformatics (2010) 1.30
A plaidoyer for 'systems immunology'. Immunol Rev (2006) 1.30
Vaccines and the future of human immunology. Immunity (2010) 1.24
Genome-wide expression analysis of placental malaria reveals features of lymphoid neogenesis during chronic infection. J Immunol (2007) 1.18
Computational mass spectrometry-based proteomics. PLoS Comput Biol (2011) 1.18
A systems biology approach to infectious disease research: innovating the pathogen-host research paradigm. MBio (2011) 1.18
Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine. J Clin Invest (2012) 1.16
The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in Mali. Vaccine (2009) 1.13
Strategies to discover regulatory circuits of the mammalian immune system. Nat Rev Immunol (2011) 1.10
Plasmodium immunomics. Int J Parasitol (2010) 1.09
Defining the humoral immune response to infectious agents using high-density protein microarrays. Future Microbiol (2010) 1.06
Successful downstream application of the Paxgene Blood RNA system from small blood samples in paediatric patients for quantitative PCR analysis. BMC Immunol (2007) 1.02
Systems vaccinology: its promise and challenge for HIV vaccine development. Curr Opin HIV AIDS (2012) 1.01
Using Laboratory Information Management Systems as central part of a proteomics data workflow. Proteomics (2010) 0.98
Metabolomics and malaria biology. Mol Biochem Parasitol (2010) 0.95
Comprehensive identification and quantification of microbial transcriptomes by genome-wide unbiased methods. Curr Opin Biotechnol (2010) 0.94
Metabonomic investigation of human Schistosoma mansoni infection. Mol Biosyst (2011) 0.92
ORFeome approach to the clonal, HLA allele-specific CD4 T-cell response to a complex pathogen in humans. J Immunol Methods (2009) 0.91
Genomics and integrated systems biology in Plasmodium falciparum: a path to malaria control and eradication. Parasite Immunol (2012) 0.90
Molecular correlates of experimental cerebral malaria detectable in whole blood. Infect Immun (2010) 0.86
Malaria's deadly secret: a skin stage. Trends Parasitol (2012) 0.86
Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature (2005) 23.04
Evolutionary discrimination of mammalian conserved non-genic sequences (CNGs). Science (2003) 3.77
Comparison of human chromosome 21 conserved nongenic sequences (CNGs) with the mouse and dog genomes shows that their selective constraint is independent of their genic environment. Genome Res (2004) 2.58
Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat Immunol (2011) 2.54
Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J Immunol (2009) 2.43
The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections. PLoS Pathog (2010) 2.03
An intensive longitudinal cohort study of Malian children and adults reveals no evidence of acquired immunity to Plasmodium falciparum infection. Clin Infect Dis (2013) 1.72
Hemoglobin S and C heterozygosity enhances neither the magnitude nor breadth of antibody responses to a diverse array of Plasmodium falciparum antigens. J Infect Dis (2011) 1.71
Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion. J Immunol (2012) 1.51
Dog Y chromosomal DNA sequence: identification, sequencing and SNP discovery. BMC Genet (2006) 1.43
Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria. J Infect Dis (2013) 1.30
Comparison of the canine and human olfactory receptor gene repertoires. Genome Biol (2003) 1.28
A positive correlation between atypical memory B cells and Plasmodium falciparum transmission intensity in cross-sectional studies in Peru and Mali. PLoS One (2011) 1.21
Construction of a 2-Mb resolution BAC microarray for CGH analysis of canine tumors. Genome Res (2005) 1.16
The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in Mali. Vaccine (2009) 1.13
Neuroprotection by endogenous and exogenous PACAP following stroke. Regul Pept (2006) 1.12
Young lives lost as B cells falter: what we are learning about antibody responses in malaria. J Immunol (2013) 1.02
Plasmodium falciparum malaria in the Peruvian Amazon, a region of low transmission, is associated with immunologic memory. Infect Immun (2012) 0.99
The HuRef Browser: a web resource for individual human genomics. Nucleic Acids Res (2008) 0.96
Plasmodium falciparum signal peptide peptidase is a promising drug target against blood stage malaria. Biochem Biophys Res Commun (2009) 0.95
Analysis of whole genome sequences of 16 strains of rubella virus from the United States, 1961-2009. Virol J (2013) 0.93
High efficiency human memory B cell assay and its application to studying Plasmodium falciparum-specific memory B cells in natural infections. J Immunol Methods (2011) 0.92
B cell analysis of ethnic groups in Mali with differential susceptibility to malaria. Malar J (2012) 0.88
Discovery of pituitary adenylate cyclase-activating polypeptide-regulated genes through microarray analyses in cell culture and in vivo. Ann N Y Acad Sci (2008) 0.88
Radiation hybrid mapping of cataract genes in the dog. Mol Vis (2006) 0.88
Neuropeptides, growth factors, and cytokines: a cohort of informational molecules whose expression is up-regulated by the stress-associated slow transmitter PACAP in chromaffin cells. Cell Mol Neurobiol (2010) 0.85
A nested real-time PCR assay for the quantification of Plasmodium falciparum DNA extracted from dried blood spots. Malar J (2014) 0.84
Cloning and characterization of canine PAX6 and evaluation as a candidate gene in a canine model of aniridia. Mol Vis (2007) 0.75